Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 496 results.
User Information
Export Records
  1. 1.   Drug-Linker Constructs Bearing Unique Dual-Mechanism Tubulin Binding Payloads Tethered through Cleavable and Non-Cleavable Linkers
  2. Ford, Jacob W; VanNatta, Jennifer M; Mondal, Deboprosad; Lin, Chen-Ming; Deng, Yuling; Bai, Ruoli; Hamel,Ernest; Trawick, Mary Lynn; Pinney, Kevin G
  3. Tetrahedron. 2025, Feb 01; 171
  1. 2.   Design, Synthesis and Biological Evaluation of 2-Phenyl Indole Analogues of OXi8006 as Colchicine Site Inhibitors of Tubulin Polymerization and Vascular Disrupting Agents
  2. Vairin, Rebecca; Tamminga, Caleb; Shi, Zhe; Borchardt, Christian; Jambulapati, Jayaram; Bai, Ruoli; Wanniarachchi, Hashini; Bueno, Lorena; Hamel,Ernest; Mason, Ralph P; Trawick, Mary Lynn; Pinney, Kevin G
  3. Bioorganic & Medicinal Chemistry. 2024, Nov 07; 118: 117981.
  1. 3.   Synthesis and Biological Evaluation of Novel 2-Aroyl Benzofuran-Based Hydroxamic Acids as Antimicrotubule Agents
  2. Mariotto, Elena; Canton, Martina; Marchioro, Chiara; Brancale, Andrea; Hamel,Ernest; Varani, Katia; Vincenzi, Fabrizio; De Ventura, Tiziano; Padroni, Chiara; Viola, Giampietro; Romagnoli, Romeo
  3. International Journal of Molecular Sciences. 2024, Jul 09; 25(14):
  1. 4.   Inhibition of Plasmodium falciparum plasmepsins by drugs targeting HIV-1 protease: A way forward for antimalarial drug discovery
  2. Mishra, Vandana; Deshmukh, Anuradha; Rathore, Ishan; Chakraborty, Satadru; Patankar, Swati; Gustchina,Alla; Wlodawer,Alexander; Yada, Rickey Y; Bhaumik, Prasenjit
  3. Current Research in Structural Biology. 2024, Jan 17; 7: 100128.
  1. 5.   First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Ra, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumors
  2. Leidner, Rom; Conlon, Kevin; McNeel, Douglas G; Wang-Gillam, Andrea; Gupta, Sumati; Wesolowski, Robert; Chaudhari, Monica; Hassounah, Nadia; Lee, Jong Bong; Ho Lee, Lang; O'Keeffe, Jessica A; Lewis, Nancy; Pavlakis,George; Thompson, John A
  3. Journal for Immunotherapy of Cancer. 2023, Oct; 11(10):
  1. 6.   Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity
  2. Tocco, Graziella; Canton, Serena; Laus, Antonio; Caboni, Pierluigi; Le Grice, Stuart F J; Tramontano, Enzo; Esposito, Francesca
  3. Molecules (Basel, Switzerland). 2023, Sep 19; 28(18):
  1. 7.   Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization
  2. Ren, Wen; Deng, Yuling; Ward, Jacob D; Vairin, Rebecca; Bai,Ruoli; Wanniarachchi, Hashini I; Hamal, Khagendra B; Tankoano, Pouguiniseli E; Tamminga, Caleb S; Bueno, Lorena M A; Hamel,Ernest; Mason, Ralph P; Trawick, Mary Lynn; Pinney, Kevin G
  3. European Journal of Medicinal Chemistry. 2023, Sep 06; 263: 115794.
  1. 8.   Structure of Complex III with Bound Antimalarial Agent CK-2-68 Provides Insights into Selective Inhibition of Plasmodium Cytochrome bc1 Complexes
  2. Esser, Lothar; Zhou, Fei; Zeher, Allison; Wu, Weimin; Huang, Rick; Yu, Chang-An; Lane, Kristin D; Wellems, Thomas E; Xia, Di
  3. The Journal of Biological Chemistry. 2023, Jul; 299(7): 104860.
  1. 9.   GSK-3a/ß and MEK inhibitors assist the microenvironment of tumor initiation
  2. Hassan, Ghmkin; Afify, Said M; Zahra, Maram H; Nawara, Hend M; Kumon, Kazuki; Iwasaki, Yoshiaki; Salomon,David; Seno, Akimasa; Seno, Masaharu
  3. Cytotechnology. 2023, Jun; 75(3): 243-253.
  1. 10.   Long-Term Safety and Efficacy of Selumetinib in Children with Neurofibromatosis Type 1 on a Phase 1/2 Trial for Inoperable Plexiform Neurofibromas
  2. Gross, Andrea M; Dombi, Eva; Wolters, Pamela L; Baldwin, Andrea; Dufek, Anne; Herrera, Kailey; Martin, Staci; Derdak, Joanne; Heisey,Kara; Whitcomb, Patricia M; Steinberg, Seth M; Venzon, David J; Fisher, Michael J; Kim, Ae Rang; Bornhorst, Miriam; Weiss, Brian D; Blakeley, Jaishri O; Smith, Malcolm A; Widemann, Brigitte C
  3. Neuro-Oncology. 2023, Apr 28;
  1. 11.   The Effect of Inositol Hexakisphosphate on HIV-1 Particle Production and Infectivity can be Modulated by Mutations that Affect the Stability of the Immature Gag Lattice
  2. Kleinpeter,Alex; Zhu, Yanan; Mallery, Donna L; Ablan,Sherimay; Chen, Long; Hardenbrook, Nathan; Saiardi, Adolfo; James, Leo C; Zhang, Peijun; Freed,Eric
  3. Journal of Molecular Biology. 2023, Apr 01; 435(11): 168037.
  1. 12.   Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression
  2. Shao, Tihong; Leung, Patrick S C; Zhang, Weici; Tsuneyama, Koichi; Ridgway, William M; Young,Howard; Shuai, Zongwen; Ansari, Aftab A; Gershwin, M Eric
  3. Cellular & Molecular Immunology. 2022, Aug 30;
  1. 13.   Dataset of high-throughput ligand screening against the RNA Packaging Signals regulating Hepatitis B Virus nucleocapsid formation
  2. Abulwerdi, Fardokht; Fatehi, Farzad; Manfield, Iain W; Le Grice,Stuart; Schneekloth,Jay; Twarock, Reidun; Stockley, Peter G; Patel, Nikesh
  3. Data in Brief. 2022, Jun; 42: 108206.
  1. 14.   The interaction of spongistatin 1 with tubulin
  2. Bai,Ruoli; Smith, Amos B; Pettit, George R; Hamel,Ernest
  3. Archives of Biochemistry and Biophysics. 2022, May 17; 109296.
  1. 15.   Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors
  2. Lai, Lick Pui; Fer,Nicole; Burgan,William; Wall,Vanessa; Xu,Bingfang; Soppet,Daniel; Esposito,Dom; Nissley,Dwight; McCormick, Frank
  3. Proceedings of the National Academy of Sciences of the United States of America. 2022, Feb 01; 119(5):
  1. 16.   WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells
  2. Datta, Arindam; Biswas, Kajal; Sommers, Joshua A.; Thompson, Haley; Awate, Sanket; Nicolae, Claudia M.; Thakar, Tanay; Moldovan, George-Lucian; Shoemaker, Robert H.; Sharan, Shyam K.; Brosh, Robert M.
  3. Nature Communications. 2021, Nov 12; 12(1):
  1. 17.   Structural insights into the function of the catalytically active human Taspase1
  2. Nagaratnam, Nirupa; Delker, Silvia L.; Jernigan, Rebecca; Edwards, Thomas E.; Snider, Janey; Thifault, Darren; Williams, Dewight; Nannenga, Brent L.; Stofega, Mary; Sambucetti, Lidia; Hsieh, James J.; Flint,Andrew; Fromme, Petra; Martin-Garcia, Jose M.
  3. Structure. 2021, Aug 5; 29(8): 873-+.
  1. 18.   Structural studies of complexes of kallikrein 4 with wild-type and mutated forms of the Kunitz-type inhibitor BbKI
  2. Li,Mi; Srp, Jaroslav; Mares, Michael; Wlodawer,Alexander; Gustchina,Alla
  3. Acta crystallographica. Section D, Structural biology. 2021, Aug 1; 77(Pt 8): 1084-1098.
  1. 19.   Potential of substituted quinazolines to interact with multiple targets in the treatment of cancer
  2. Choudhary, Shruti; Doshi, Arpit; Luckett-Chastain, Lerin; Ihnat, Michael; Hamel,Ernest; Mooberry, Susan L.; Gangjee, Aleem
  3. Bioogranic & Medicinal Chemistry. 2021, Apr 1; 35
  1. 20.   Insight on [1,3]thiazolo[4,5-e]isoindoles as tubulin polymerization inhibitors
  2. Spano, Virginia; Barreca, Marilia; Rocca, Roberta; Bortolozzi, Roberta; Bai, Ruoli; Carbone, Anna; Raimondi, Maria Valeria; Piccionello, Antonio Palumbo; Montalbano, Alessandra; Alcaro, Stefano; Hamel, Ernest; Viola, Giampietro; Barraja, Paola
  3. European Journal of Medicinal Chemistry. 2021, Feb 15; 212
  1. 21.   Harnessing Ionic Selectivity in Acetyltransferase Chemoproteomic Probes
  2. Jing, Yihang; Montano, Jose L.; Levy, Michaella; Lopez, Jeffrey E.; Kung, Pei-Pei; Richardson, Paul; Krajewski, Krzysztof; Florens, Laurence; Washburn, Michael P.; Meier, Jordan L.
  3. ACS Chemical Biology. 2021, Jan 15; 16(1): 27-34.
  1. 22.   Scaffold hopping and optimisation of 3',4'-dihydroxyphenyl- containing thienopyrimidinones: synthesis of quinazolinone derivatives as novel allosteric inhibitors of HIV-1 reverse transcriptase-associated ribonuclease H
  2. Tocco, Graziella; Esposito, Francesca; Caboni, Pierluigi; Laus, Antonio; Beutler,John; Wilson,Jennifer; Corona, Angela; Le Grice,Stuart; Tramontano, Enzo
  3. Journal of enzyme inhibition and medicinal chemistry. 2020, Dec; 35(1): 1953-1963.
  1. 23.   Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy
  2. Krug, Karsten; Jaehnig, Eric J; Satpathy, Shankha; Blumenberg, Lili; Karpova, Alla; Anurag, Meenakshi; Miles, George; Mertins, Philipp; Geffen, Yifat; Tang, Lauren C; Heiman, David I; Cao, Song; Maruvka, Yosef E; Lei, Jonathan T; Huang, Chen; Kothadia, Ramani B; Colaprico, Antonio; Birger, Chet; Wang, Jarey; Dou, Yongchao; Wen, Bo; Shi, Zhiao; Liao, Yuxing; Wiznerowicz, Maciej; Wyczalkowski, Matthew A; Chen, Xi Steven; Kennedy, Jacob J; Paulovich, Amanda G; Thiagarajan,Mathangi; Kinsinger, Christopher R; Hiltke, Tara; Boja, Emily S; Mesri, Mehdi; Robles, Ana I; Rodriguez, Henry; Westbrook, Thomas F; Ding, Li; Getz, Gad; Clauser, Karl R; Fenyö, David; Ruggles, Kelly V; Zhang, Bing; Mani, D R; Carr, Steven A; Ellis, Matthew J; Gillette, Michael A
  3. Cell. 2020, NOV 25; 183(5): 1436-+.
  1. 24.   Exploring role of 5hmC as potential marker of chemoresistance
  2. Kharat,Suhas; Sharan,Shyam
  3. MOLECULAR & CELLULAR ONCOLOGY. 2020, Oct 22; 7(6): 1827904.
  1. 25.   A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components
  2. Nilsson, Monique B.; Sun, Huiying; Robichaux, Jacqulyne; Pfeifer, Matthias; McDermott, Ultan; Travers, Jon; Diao, Lixia; Xi, Yuanxin; Tong, Pan; Shen, Li; Hofstad, Mia; Kawakami, Masanori; Le, Xiuning; Liu, Xi; Fan, Youhong; Poteete, Alissa; Hu, Limei; Negrao, Marcelo; Tran, Hai; Dmitrovsky, Ethan; Peng, David; Gibbons, Don L.; Wang, Jing; Heymach, John
  3. SCIENCE TRANSLATIONAL MEDICINE. 2020, SEP 2; 12(559): pii: aaz4589.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel